Press Release by Frutarom Industries Ltd.
Enzymotec Ltd. Expands VAYA Product Portfolio with Five Nutritional Supplements Acquired from Union Springs Healthcare
Enzymotec Ltd. (Nasdaq: ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional products, today announced that it has acquired all rights
The novel, soy-allergen free, non GMO Phosphatidylserine product -Sharp-PS® GREEN by Enzymotec, has received GRAS status from the FDA. This status allows the marketing and
Enzymotec’s High-potency K·REAL® krill oil gains EU Novel Food approval, allowing additional health claims
Enzymotec announced that its high-potency grade of K·Real® krill oil has received Novel Food approval from the European Commission (EC). This approval allows high grades
Enzymotec Ltd., a developer, manufacturer and marketer of innovative bio-active lipid ingredients, recently announced the appointment of Holger Liepmann to its Board of Directors. Holger
Enzymotec strengthen its global position in the omega 3 market with new granted “Master patents” in USA and Australia for phospholipid based products.
Enzymotec Ltd., a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that it was granted patents by the U.S. Patent and Trademark